Host serum miR-223 is a potential new biomarker for Schistosoma japonicum infection and the response to chemotherapy

Parasites and Vectors

Volumn 6, Issue 1, 2013, Pages

  He, Xing ^a   Sai, Xue ^a   Chen, Chao ^a   Zhang, Yuanbin ^b   Xu, Xindong ^b   Zhang, Dongmei ^a   Pan, Weiqing ^a,b  

^a SECOND MILITARY MEDICAL UNIVERSITY   (China)

^b TONGJI UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

Biomarker; Praziquantel; Schistosoma japonicum; Schistosomiasis; Serum miRNA

Indexed keywords

HYDROXYPROLINE; MICRORNA; MICRORNA 122; MICRORNA 146B; MICRORNA 199A 3P; MICRORNA 199A 5P; MICRORNA 223; PRAZIQUANTEL; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BIOINFORMATICS; BLOOD SAMPLING; CHEMOTHERAPY; CONTROLLED STUDY; DISEASE MARKER; DNA BINDING; KUPFFER CELL; LIVER; LIVER FIBROSIS; MOLECULE; MOUSE; NONHUMAN; RABBIT; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION; SCHISTOSOMIASIS; SCHISTOSOMIASIS JAPONICA; STELLATE CELL; TREATMENT RESPONSE;

BUBALUS; MUS; ORYCTOLAGUS CUNICULUS; SCHISTOSOMA; SCHISTOSOMA JAPONICUM;

ANIMALS; BIOLOGICAL MARKERS; BUFFALOES; GENE EXPRESSION REGULATION; HUMANS; HYDROXYPROLINE; MALE; MICE; MICE, INBRED BALB C; MICRORNAS; RABBITS; SCHISTOSOMA JAPONICUM; SCHISTOSOMIASIS JAPONICA; SCHISTOSOMICIDES;

EID: 84884313530     PISSN: None     EISSN: 17563305     Source Type: Journal    
DOI: 10.1186/1756-3305-6-272     Document Type: Article

References (38)

1. Human schistosomiasis. Gryseels B, Polman K, Clerinx J, Kestens L, Lancet 2006 368 1106 1118 10.1016/S0140-6736(06)69440-3 16997665 (Pubitemid 44402679)
2. Schistosomiasis elimination: lessons from the past guide the future. Gray DJ, McManus DP, Li YS, Williams GM, Bergquist R, Ross AG, Lancet Infect Dis 2010 10 733 736 10.1016/S1473-3099(10)70099-2 20705513
3. Factors impacting on progress towards elimination of transmission of schistosomiasis japonica in China. Zhou YB, Liang S, Jiang QW, Parasit Vectors 2012 5 275 10.1186/1756-3305-5-275 23206326
4. Optimizing molluscicide treatment strategies in different control stages of schistosomiasis in the People's Republic of China. Yang GJ, Sun LP, Hong QB, Zhu HR, Yang K, Gao Q, Zhou XN, Parasit Vectors 2012 5 260 10.1186/1756-3305-5- 260 23151396
5. Drugs for the control of parasitic diseases: current status and development in schistosomiasis. Fenwick A, Savioli L, Engels D, Robert Bergquist N, Todd MH, Trends Parasitol 2003 19 509 515 10.1016/j.pt.2003.09.005 14580962 (Pubitemid 37329660)
6. Anti-inflammatory/anti-fibrotic effects of the hepatoprotective silymarin and the schistosomicide praziquantel against Schistosoma mansoni-induced liver fibrosis. El-Lakkany NM, Hammam OA, El-Maadawy WH, Badawy AA, Ain-Shoka AA, Ebeid FA, Parasit Vectors 2012 5 9 10.1186/1756-3305-5-9 22236605
7. MicroRNAs: genomics, biogenesis, mechanism, and function. Bartel DP, Cell 2004 116 281 297 10.1016/S0092-8674(04)00045-5 14744438 (Pubitemid 38167318)
8. Roles for microRNAs in conferring robustness to biological processes. Ebert MS, Sharp PA, Cell 2012 149 515 524 10.1016/j.cell.2012.04.005 22541426
9. MicroRNAs in cell proliferation, cell death, and tumorigenesis. Hwang HW, Mendell JT, Br J Cancer 2006 94 776 780 10.1038/sj.bjc.6603023 16495913
10. Emerging role of microRNAs in liver diseases. Bala S, Marcos M, Szabo G, World J Gastroenterol 2009 15 5633 5640 10.3748/wjg.15.5633 19960558
11. Nonalcoholic steatohepatitis is associated with altered hepatic MicroRNA expression. Cheung O, Puri P, Eicken C, Contos MJ, Mirshahi F, Maher JW, Kellum JM, Min H, Luketic VA, Sanyal AJ, Hepatology 2008 48 1810 1820 10.1002/hep.22569 19030170
12. The progression of liver fibrosis is related with overexpression of the miR-199 and 200 families. Murakami Y, Toyoda H, Tanaka M, Kuroda M, Harada Y, Matsuda F, Tajima A, Kosaka N, Ochiya T, Shimotohno K, PLoS One 2011 6 16081 10.1371/journal.pone.0016081 21283674
13. Comparison of the differential expression miRNAs in Wistar rats before and 10 days after S. japonicum infection. Han H, Peng J, Hong Y, Zhang M, Han Y, Fu Z, Shi Y, Xu J, Tao J, Lin J, Parasit Vectors 2013 6 120 10.1186/1756-3305-6-120 23617945
14. miR-182 and miR-10a are key regulators of Treg specialisation and stability during Schistosome and Leishmania-associated inflammation. Kelada S, Sethupathy P, Okoye IS, Kistasis E, Czieso S, White SD, Chou D, Martens C, Ricklefs SM, Virtaneva K, et al. PLoS Pathog 2013 9 1003451 10.1371/journal. ppat.1003451 23825948
15. Characterization of microRNAs in serum: a novel class of biomarkers for diagnosis of cancer and other diseases. Chen X, Ba Y, Ma L, Cai X, Yin Y, Wang K, Guo J, Zhang Y, Chen J, Guo X, et al. Cell Res 2008 18 997 1006 10.1038/cr.2008.282 18766170
16. Circulating microRNAs as stable blood-based markers for cancer detection. Mitchell PS, Parkin RK, Kroh EM, Fritz BR, Wyman SK, Pogosova-Agadjanyan EL, Peterson A, Noteboom J, O'Briant KC, Allen A, et al. Proc Natl Acad Sci U S A 2008 105 10513 10518 10.1073/pnas.0804549105 18663219
17. Serum microRNAs as non-invasive biomarkers for cancer. Brase JC, Wuttig D, Kuner R, Sültmann H, Mol Cancer 2010 9 306 10.1186/1476-4598-9-306 21110877
18. Circulating microRNAs, miR-21, miR-122, and miR-223, in patients with hepatocellular carcinoma or chronic hepatitis. Xu J, Wu C, Che X, Wang L, Yu D, Zhang T, Huang L, Li H, Tan W, Wang C, Lin D, Mol Carcinog 2011 50 136 142 10.1002/mc.20712 21229610
19. Serum miR-146a and miR-223 as potential new biomarkers for sepsis. Wang JF, Yu ML, Yu G, Bian JJ, Deng XM, Wan XJ, Zhu KM, Biochem Biophys Res Commun 2010 394 184 188 10.1016/j.bbrc.2010.02.145 20188071
20. Circulating microRNAs, potential biomarkers for drug-induced liver injury. Wang K, Zhang S, Marzolf B, Troisch P, Brightman A, Hu Z, Hood LE, Galas DJ, Proc Natl Acad Sci U S A 2009 106 4402 4407 10.1073/pnas.0813371106 19246379
21. An «in-depth» description of the small non-coding RNA population of Schistosoma japonicum schistosomulum. Wang Z, Xue X, Sun J, Luo R, Xu X, Jiang Y, Zhang Q, Pan W, PLoS Negl Trop Dis 2010 4 596 10.1371/journal.pntd.0000596 20161724
22. Analysis of circulating microRNA biomarkers in plasma and serum using quantitative reverse transcription-PCR (qRT-PCR). Kroh EM, Parkin RK, Mitchell PS, Tewari M, Methods 2010 50 298 301 10.1016/j.ymeth.2010.01.032 20146939
23. Real-time quantification of microRNAs by stem-loop RT-PCR. Chen C, Ridzon DA, Broomer AJ, Zhou Z, Lee DH, Nguyen JT, Barbisin M, Xu NL, Mahuvakar VR, Andersen MR, et al. Nucleic Acids Res 2005 33 179 10.1093/nar/gni178 16314309 (Pubitemid 41806407)
24. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Livak KJ, Schmittgen TD, Methods 2001 25 402 408 10.1006/meth.2001.1262 11846609 (Pubitemid 34164012)
25. Role for hedgehog signaling in hepatic stellate cell activation and viability. Sicklick JK, Li YX, Choi SS, Qi Y, Chen W, Bustamante M, Huang J, Zdanowicz M, Camp T, Torbenson MS, et al. Lab Invest 2005 85 1368 1380 10.1038/labinvest.3700349 16170335 (Pubitemid 41509385)
26. Toll-like receptor 4-dependent Kupffer cell activation and liver injury in a novel mouse model of parenteral nutrition and intestinal injury. El Kasmi KC, Anderson AL, Devereaux MW, Fillon SA, Harris JK, Lovell MA, Finegold MJ, Sokol RJ, Hepatology 2012 55 1518 1528 10.1002/hep.25500 22120983
27. The Gene Ontology (GO) project in 2006. Gene Ontology Consortium, Nucleic Acids Res 2006 34 322 326 10.1093/nar/gkj439 16410612 (Pubitemid 43160055)
28. Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets. Lewis BP, Burge CB, Bartel DP, Cell 2005 120 15 20 10.1016/j.cell.2004.12.035 15652477 (Pubitemid 40094598)
29. Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. da Huang W, Sherman BT, Lempicki RA, Nat Protoc 2009 4 44 57 19131956
30. Detection of elevated levels of tumour-associated microRNAs in serum of patients with diffuse large B-cell lymphoma. Lawrie CH, Gal S, Dunlop HM, Pushkaran B, Liggins AP, Pulford K, Banham AH, Pezzella F, Boultwood J, Wainscoat JS, et al. Br J Haematol 2008 141 672 675 10.1111/j.1365-2141.2008. 07077.x 18318758 (Pubitemid 351667616)
31. Circulating microRNAs in breast cancer and healthy subjects. Zhu W, Qin W, Atasoy U, Sauter ER, BMC Res Notes 2009 2 89 10.1186/1756-0500-2-89 19454029
32. The detection of differentially expressed microRNAs from the serum of ovarian cancer patients using a novel real-time PCR platform. Resnick KE, Alder H, Hagan JP, Richardson DL, Croce CM, Cohn DE, Gynecol Oncol 2009 112 55 59 10.1016/j.ygyno.2008.08.036 18954897
33. MicroRNAs in plasma of pancreatic ductal adenocarcinoma patients as novel blood-based biomarkers of disease. Wang J, Chen J, Chang P, LeBlanc A, Li D, Abbruzzesse JL, Frazier ML, Killary AM, Sen S, Cancer Prev Res (Phila Pa) 2009 2 807 813 10.1158/1940-6207.CAPR-09-0094
34. Plasma microRNAs are promising novel biomarkers for early detection of colorectal cancer. Huang Z, Huang D, Ni S, Peng Z, Sheng W, Du X, Int J Cancer 2010 127 118 126 10.1002/ijc.25007 19876917
35. Down-regulation of miR-92 in human plasma is a novel marker for acute leukemia patients. Tanaka M, Oikawa K, Takanashi M, Kudo M, Ohyashiki J, Ohyashiki K, Kuroda M, PLoS ONE 2009 4 5532 10.1371/journal.pone.0005532 19440243
36. Plasma miR-208 as a biomarker of myocardial injury. Ji X, Takahashi R, Hiura Y, Hirokawa G, Fukushima Y, Iwai N, Clin Chem 2009 55 1944 1949 10.1373/clinchem.2009.125310 19696117
37. Exosomemediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells. Valadi H, Ekstrom K, Bossios A, Sjostrand M, Lee JJ, Lotvall JO, Nat Cell Biol 2007 9 654 659 10.1038/ncb1596 17486113 (Pubitemid 47214727)
38. Macrophage activation governs schistosomiasis-induced inflammation and fibrosis. Barron L, Wynn TA, Eur J Immunol 2011 41 2509 2514 10.1002/eji.201141869 21952807